Statins: when stopping is appropriate (and when it isn’t)

Dr Dan Reardon

Dr Dan Reardon MB ChB, BSc (Anatomy), MSc (Mental Health) is a medical doctor and lifestyle medicine clinician who writes about deprescribing, metabolic health, and behaviour change. His articles draw on primary sources (e.g., MHRA/FDA prescribing information, pivotal clinical trials, and peer-reviewed systematic reviews/meta-analyses) and are updated as evidence and guidance evolve. He continues to practise in NHS Accident & Emergency, operate privately from Sutton Medical Consulting, and leads Go Metabolic, combining clinical judgement with real-world physiology, lab data, and practical implementation for patients aiming to reduce medication burden safely.

https://drdanreardon.com
Previous
Previous

Coming Off Mounjaro (Tirzepatide): What to Expect, By Week

Next
Next

PPI rebound explained